FGF2 stimulates osteogenic differentiation through ERK induced TAZ expression

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• TAZ (transcriptional coactivator with PDZ-binding motif) is a key regulator of mesenchymal stem cell differentiation, promoting osteogenesis and inhibiting adipogenesis.
• Fibroblast growth factors (FGFs) are involved in cell proliferation, differentiation, and survival, with FGF2 known to stimulate osteoblast differentiation through poorly understood mechanisms.

Purpose of the Study:

• To elucidate the role of TAZ in mediating FGF2 signaling during osteogenesis.
• To investigate the molecular mechanisms by which FGF2 influences TAZ expression and activity in osteoblasts.

Main Methods:

• Quantitative analysis of TAZ mRNA and protein expression.
• Functional assays using small hairpin RNA (shRNA) to deplete TAZ.
• Western blotting to assess ERK activation and nuclear localization of TAZ.
• Chromatin immunoprecipitation (ChIP) assays to evaluate Runx2-mediated gene transcription.

Main Results:

• FGF2 treatment significantly increased TAZ expression at both mRNA and protein levels.
• Depletion of TAZ using shRNA abolished FGF2-induced osteogenic differentiation.
• ERK activation was found to be essential for FGF2-induced TAZ expression.
• FGF2 promoted the nuclear translocation of TAZ, enhancing its interaction with Runx2 and subsequent activation of Runx2 target genes.

Conclusions:

• TAZ acts as a critical mediator of FGF2 signaling in the context of osteoblast differentiation.
• The FGF2-ERK-TAZ signaling axis plays a pivotal role in regulating osteogenic gene expression and differentiation.